Evidence map›Paper›PMID 31086250›Full record

Trial reportScientific reports2019

Effects of diaphragmatic myofascial release on gastroesophageal reflux disease: a preliminary randomized controlled trial.

I Martínez-Hurtado, M D Arguisuelas, P Almela-Notari, X Cortés, A Barrasa-Shaw, J C Campos-González, J F Lisón

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05283447 (Effectiveness of Manual Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients With Type I Hiatal Hernia), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05283447 nacompletednot on this mapstarted 2022, after this paper: background citation

Effectiveness of Manual Therapy in the Treatment of Gastroesophageal Reflux Disease in Patients With Type I Hiatal Hernia

TypeinterventionalSponsorEscoles Universitaries GimbernatRan2022 to 2023Enrolled44ConditionsGastroesophageal RefluxArmsOsteopathic Medicine, Control
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Effect of manual diaphragmatic release on ventilatory function and functional capacity in elderly type 2 diabetic women: A randomised controlled trial.Hong Kong physiotherapy journal : official publication of the Hong Kong Physiotherapy Association Limited = Wu li chih liao · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

I Martínez-HurtadoDepartment of Physiotherapy, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
M D ArguisuelasDepartment of Physiotherapy, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
P Almela-NotariDepartment of Gastroenterology, Hospital General de Castellón, Castellón, Spain.
X CortésDepartment of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
A Barrasa-ShawDepartment of Surgery, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
J C Campos-GonzálezDepartment of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
J F LisónDepartment of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain. juanfran@uchceu.es.
Universidad Cardenal Herrera CEU · ESHospitales Nisa · ESHospital General Universitari de Castelló · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study is to investigate whether implementing a myofascial release (MFR) protocol designed to restore the myofascial properties of the diaphragm has any effect on the symptoms, quality of life, and consumption of proton pump inhibitors (PPI) drugs by patients with non-erosive gastroesophageal reflux disease (GERD). We randomized 30 patients with GERD into a MFR group or a sham group. Changes in symptomatology and quality of life were measured with the Reflux Disease Questionnaire and the Gastrointestinal Quality of Life Index. Need of PPIs was measured as the milligrams of drug intake over the 7 days prior to each assessment. All variables were assessed at baseline, one week and 4 weeks after the end of the treatment. At week 4, patients receiving MFR showed significant improvements in symptomatology (mean difference-1.1; 95% CI: -1.7 to -0.5), gastrointestinal quality of life (mean difference 18.1; 95% CI: 4.8 to 31.5), and PPIs use (mean difference-97 mg; 95% CI: -162 to -32), compared to the sham group. These preliminary findings indicate that the application of the MFR protocol we used in this study decreased the symptoms and PPIs usage and increased the quality of life of patients with non-erosive GERD up to four weeks after the end of the treatment.

Indexed as

DiaphragmFemaleGastroesophageal RefluxHumansMaleMassageProton Pump InhibitorsQuality of LifeSurveys and QuestionnairesTreatment OutcomeProton Pump Inhibitors

Identifiers

PMID31086250
PMCPMC6513998
OpenAlexW2945565644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.